1. Trading Members are hereby informed that Sun Pharmaceutical Industries Limited (Scrip code: 524715) has announced buyback of its fully paid-up equity shares of face value of Rs. 1/- each from the Open Market through electronic trading mechanism of the Exchange. The Maximum Buyback Price would not exceed Rs. 425/- (Rupees Four Hundred twenty five only) per equity share payable in cash for an aggregate amount not exceeding INR 17,00,00,00,000/- (Indian Rupees One Thousand Seven Hundred Crores only.
2. Proposed timetable for buyback:
|
Date of Opening of the Buyback on BOLT
|
Thursday, March 26, 2020
|
|
Last Date for the Buyback
|
Earlier of:
a) Friday, September 25, 2020 i.e., within 6 months from the date of the opening of Buy-back; or
b) When the Company completes the Buy-back by deploying the amount equivalent to the Maximum Buy-back Size; or
c) At such earlier date as may be determined by the Board or the persons authorised by the Board, subject to the Company having deployed an amount equivalent to the Minimum Buy-back Size (even if the Maximum Buy-back Size has not been reached).
|
3. Broker Members for buyback:
The company has appointed the following BSE Trading Members through whom the purchases and settlement on account of the buyback would be made:
|
Name of the Member ‘s
|
Clearing No
|
|
IDFC Securities Limited
|
623
|
|
Sunidhi Securities & Finance Limited
|
0291
|
4. Details of Shares held in DEMAT Form.
The Trading Members may note that the Equity Shares held in DEMAT form can be offered for Buyback to the Company in rolling settlement, as per details mentioned below:
Scrip Code No. : 524715
Market Lot : 1 Share
Scrip ID on BOLT System : SUNPHARMA*
5. Circuit Filters, Margins, Capital Adequacy Norms, Auction, Close out, Bad Delivery, Arbitration, etc. are applicable in case of buyback as in the case of the normal trading.
6. Institutional Investors are allowed to participate in the buyback.
7. The documents are available in Department of Corporate Services for inspection. In case of any queries /clarifications on the scheme of buyback, Trading Members may please contact the under mentioned persons:
- Merchant Banker to the Buyback:
Vivro Financial Services Private Limited
607, 608 Marathon Icon, Opp. Peninsula Corporate Park,
Off Ganpatrao Kadam Marg, Veer Santaji Lane,
Lower Parel, Mumbai – 400 013.
Tel.: +91 22 6666 8040/41/42
Fax: +91 22 6666 8047
Contact Person: Mr. Harish Patel / Mr. Bhargav Parekh
Email: investors@vivro.net
Website: www.vivro.net
Mr. Ashok I Bhuta (Compliance Officer)
Mr. Sunil Ajmera (Company Secretary & Compliance Officer)
SUN House, CTS No. 201 B/1, Western Express Highway,
Goregaon (E), Mumbai – 400063, Maharashtra, India
Telephone: +91 22 4324 4324
Fax: +91 22 4324 4343
Email: secretarial@sunpharma.co
Website: www.sunpharma.com
· At the Exchange:
Clearing & Settlement Department -
Mr. Nilesh Shah/Ajay Darji - Extn: 022-2272-8704/8468 (For Clearing & Settlement)
Trading Department -
Trading Operations - Extn: 022-2272- 8376 (For Trading Related)
Help desk - Extn: 61363100 (Hunting) (For BOLT System)
Listing Operations Department –
Mr. Raghavendra Bhat - Extn: 022-2272-8915 (For General Queries)
Rupal Khandelwal
Senior Manager
March 25, 2020 |